Found: 99
Select item for more details and to access through your institution.
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 709, doi. 10.1007/s10637-018-0579-8
- By:
- Publication type:
- Article
Sensitivity and specificity of a self-administered questionnaire for familial screening of adult-onset dystonia.
- Published in:
- Movement Disorders, 2006, v. 21, n. 4, p. 571, doi. 10.1002/mds.20760
- By:
- Publication type:
- Article
Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 12, p. 1229, doi. 10.1111/hepr.13718
- By:
- Publication type:
- Article
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
- Published in:
- Hepatology Research, 2021, v. 51, n. 7, p. 796, doi. 10.1111/hepr.13669
- By:
- Publication type:
- Article
Survey of period variations of superhumps in SU UMa-type dwarf novae. V. The fifth year (2012–2013).
- Published in:
- Publications of the Astronomical Society of Japan, 2014, v. 66, n. 2, p. 1, doi. 10.1093/pasj/psu014
- By:
- Publication type:
- Article
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 370, doi. 10.1159/000515551
- By:
- Publication type:
- Article
Menopause and Menarche in Patients with Primary Blepharospasm: An Exploratory Case-Control Study.
- Published in:
- European Neurology, 2002, v. 47, n. 3, p. 161, doi. 10.1159/000047975
- By:
- Publication type:
- Article
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 314, doi. 10.1016/j.clcc.2021.07.001
- By:
- Publication type:
- Article
Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Adjuvant Systemic Chemotherapy After Putative Curative Resection of Colorectal Liver and Lung Metastases.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 188, doi. 10.1016/j.clcc.2013.04.002
- By:
- Publication type:
- Article
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen.
- Published in:
- 2012
- By:
- Publication type:
- journal article
IL PAZIENTE ONCOLOGICO E I MECCANISMI DI CARDIOTOSSICITÀ.
- Published in:
- Outpatient Cardiology / Cardiologia Ambulatorial, 2023, v. 31, n. 2, p. 93, doi. 10.17473/1971-6818-2023-2-2
- By:
- Publication type:
- Article
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e245635, doi. 10.1001/jamanetworkopen.2024.5635
- By:
- Publication type:
- Article
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060892
- By:
- Publication type:
- Article
Advances, Challenges, and Future Perspectives of Microwave Reflectometry for Plasma Position and Shape Control on Future Nuclear Fusion Devices.
- Published in:
- Sensors (14248220), 2023, v. 23, n. 8, p. 3926, doi. 10.3390/s23083926
- By:
- Publication type:
- Article
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Liver International, 2021, v. 41, n. 12, p. 2997, doi. 10.1111/liv.15014
- By:
- Publication type:
- Article
Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1389, doi. 10.1111/liv.14817
- By:
- Publication type:
- Article
Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 1, p. 21, doi. 10.1093/jnci/djq456
- By:
- Publication type:
- Article
The Role of Thermal Effects in Plasma Medical Applications: Biological and Calorimetric Analysis.
- Published in:
- Applied Sciences (2076-3417), 2019, v. 9, n. 24, p. 5560, doi. 10.3390/app9245560
- By:
- Publication type:
- Article
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 7, p. 1391, doi. 10.1038/s41416-023-02180-7
- By:
- Publication type:
- Article
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 957, doi. 10.1038/s41416-022-01852-0
- By:
- Publication type:
- Article
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
- Published in:
- 2022
- By:
- Publication type:
- journal article
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 6, p. 958, doi. 10.1007/s10120-023-01411-3
- By:
- Publication type:
- Article
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology.
- Published in:
- Oncology, 2024, v. 102, n. 2, p. 157, doi. 10.1159/000533406
- By:
- Publication type:
- Article
Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy.
- Published in:
- Oncology, 2023, v. 101, n. 7, p. 435, doi. 10.1159/000530853
- By:
- Publication type:
- Article
Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.
- Published in:
- Oncology, 2016, v. 91, n. 5, p. 283, doi. 10.1159/000448004
- By:
- Publication type:
- Article
Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward?
- Published in:
- Oncology, 2014, v. 86, n. 4, p. 191, doi. 10.1159/000358599
- By:
- Publication type:
- Article
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 75, doi. 10.1159/000329079
- By:
- Publication type:
- Article
Use of a new cold plasma tool for psoriasis treatment: A case report.
- Published in:
- SAGE Open Medical Case Reports, 2020, v. 8, p. 1, doi. 10.1177/2050313X20922709
- By:
- Publication type:
- Article
The first confirmed superoutburst of the dwarf nova GALEX J215818.5+241924.
- Published in:
- Journal of the British Astronomical Association, 2013, v. 123, n. 1, p. 42
- By:
- Publication type:
- Article
The orbital and superhump periods of the deeply eclipsing dwarf nova SDSS J150240.98+333423.9.
- Published in:
- Journal of the British Astronomical Association, 2011, v. 121, n. 2, p. 96
- By:
- Publication type:
- Article
Comet disruption: a statistical approach for the nearly isotropic comets.
- Published in:
- Journal of the British Astronomical Association, 2009, v. 119, n. 4, p. 203
- By:
- Publication type:
- Article
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 9379, doi. 10.2147/CMAR.S330195
- By:
- Publication type:
- Article
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 3, p. 363, doi. 10.1007/s10147-023-02295-0
- By:
- Publication type:
- Article
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5591, doi. 10.1007/s00432-022-04512-1
- By:
- Publication type:
- Article
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3665, doi. 10.1007/s00432-021-03602-w
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1895, doi. 10.1002/onco.13886
- By:
- Publication type:
- Article
FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 302, doi. 10.1002/onco.13642
- By:
- Publication type:
- Article
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. 886, doi. 10.1634/theoncologist.2019-0922
- By:
- Publication type:
- Article
Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1178, doi. 10.1634/theoncologist.2017-0573
- By:
- Publication type:
- Article
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 8, p. 988, doi. 10.1634/theoncologist.2016-0084
- By:
- Publication type:
- Article
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice.
- Published in:
- Oncologist, 2008, v. 13, n. 12, p. 1270, doi. 10.1634/theoncologist.2008-0181
- By:
- Publication type:
- Article
Motoneuron disease after electric injury: a case report.
- Published in:
- Neurological Sciences, 2008, v. 29, n. 1, p. 47, doi. 10.1007/s10072-008-0860-2
- By:
- Publication type:
- Article
Surgery combined with intra-operative microwaves ablation for the management of colorectal cancer liver metastasis: A case-matched analysis and evaluation of recurrences.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1023301
- By:
- Publication type:
- Article
5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2001, v. 61, n. 1, p. 28, doi. 10.1159/000055349
- By:
- Publication type:
- Article